全文获取类型
收费全文 | 3346篇 |
免费 | 422篇 |
国内免费 | 1篇 |
出版年
2021年 | 33篇 |
2020年 | 34篇 |
2019年 | 34篇 |
2018年 | 45篇 |
2017年 | 41篇 |
2016年 | 62篇 |
2015年 | 115篇 |
2014年 | 98篇 |
2013年 | 152篇 |
2012年 | 165篇 |
2011年 | 153篇 |
2010年 | 106篇 |
2009年 | 94篇 |
2008年 | 155篇 |
2007年 | 142篇 |
2006年 | 153篇 |
2005年 | 134篇 |
2004年 | 138篇 |
2003年 | 128篇 |
2002年 | 94篇 |
2001年 | 86篇 |
2000年 | 124篇 |
1999年 | 89篇 |
1998年 | 35篇 |
1997年 | 36篇 |
1996年 | 31篇 |
1995年 | 32篇 |
1994年 | 32篇 |
1993年 | 41篇 |
1992年 | 72篇 |
1991年 | 65篇 |
1990年 | 70篇 |
1989年 | 61篇 |
1988年 | 58篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 53篇 |
1984年 | 43篇 |
1983年 | 40篇 |
1982年 | 28篇 |
1981年 | 32篇 |
1980年 | 35篇 |
1979年 | 36篇 |
1978年 | 42篇 |
1977年 | 38篇 |
1975年 | 36篇 |
1974年 | 31篇 |
1973年 | 27篇 |
1972年 | 28篇 |
1971年 | 23篇 |
排序方式: 共有3769条查询结果,搜索用时 31 毫秒
61.
62.
63.
64.
Lili Lu Christopher P. Seidel Takeshi Iwase Rebecca K. Stevens Yuan‐Yuan Gong Xinyi Wang Sean F. Hackett Peter A. Campochiaro 《Journal of cellular physiology》2013,228(2):251-257
High blood glucose results in high glucose levels in retina, because GLUT1, the sole glucose transporter between blood and retina, transports more glucose when blood glucose is high. This is the ultimate cause of diabetic retinopathy. Knockdown of GLUT1 by intraocular injections of a pool of siRNAs directed against SLC2A1 mRNA which codes for GLUT1 significantly reduced mean retinal glucose levels in diabetic mice. Systemic treatment of diabetic mice with forskolin or genistein, which bind GLUT1 and inhibit glucose transport, significantly reduced retinal glucose to the same levels seen in non‐diabetics. 1,9‐Dideoxyforskolin, which binds GLUT1 but does not stimulate adenylate cyclase had an equivalent effect to that of forskolin regarding lowering retinal glucose in diabetics indicating that cyclic AMP is noncontributory. GLUT1 inhibitors also reduced glucose and glycohemoglobin levels in red blood cells providing a peripheral biomarker for the effect. In contrast, brain glucose levels were not increased in diabetics and not reduced by forskolin. Treatment of diabetics with forskolin prevented early biomarkers of diabetic retinopathy, including elevation of superoxide radicals, increased expression of the chaperone protein β2 crystallin, and increased expression of vascular endothelial growth factor (VEGF). These data identify GLUT1 as a promising therapeutic target for prevention of diabetic retinopathy. J. Cell. Physiol. 228: 251–257, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
65.
66.
67.
68.
69.
70.
Jasper Stevens Dirk-Jan van den Berg Sanne de Ridder Harm A.G. Niederländer Piet Hein van der Graaf Meindert Danhof Elizabeth C.M. de Lange 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2010,878(13-14):969-975
Remoxipride is a selective dopamine D2 receptor antagonist, and useful as a model compound in mechanism-based pharmacological investigations. To that end, studies in small animals with serial sampling over time are needed. For these small volume samples currently no suitable analytical methods are available. We propose analytical methods for the detection of low concentrations remoxipride in small sample volumes of plasma, brain homogenate, and brain microdialysate, using online solid phase extraction with liquid chromatography–tandem mass spectrometry. Method development, optimization and validation are described in terms of calibration curves, extraction yield, lower limit of quantification (LLOQ), precision, accuracy, inter-day- and intra-day variability. The 20 μl plasma samples showed an extraction yield of 76%, with a LLOQ of 0.5 ng/ml. For 0.6 ml brain homogenate samples the extraction yield was 45%, with a LLOQ of 1.8 ng/ml. The 20 μl brain microdialysate samples, without pre-treatment, had a LLOQ of 0.25 ng/ml. The precision and accuracy were well within the acceptable 15% range. Considering the small sample volumes, the high sensitivity and good reproducibility, the analytical methods are suitable for analyzing small sample volumes with low remoxipride concentrations. 相似文献